FR2948381B1 - Procede d'obtention de myofibroblastes. - Google Patents

Procede d'obtention de myofibroblastes.

Info

Publication number
FR2948381B1
FR2948381B1 FR0955216A FR0955216A FR2948381B1 FR 2948381 B1 FR2948381 B1 FR 2948381B1 FR 0955216 A FR0955216 A FR 0955216A FR 0955216 A FR0955216 A FR 0955216A FR 2948381 B1 FR2948381 B1 FR 2948381B1
Authority
FR
France
Prior art keywords
identification
myofibroblasts
cells
myofibroblast
population
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0955216A
Other languages
English (en)
French (fr)
Other versions
FR2948381A1 (fr
Inventor
Nicolas Jacques Rouyer
Robert Barthel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ONCOBIOTEK
Original Assignee
ONCOBIOTEK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0955216A priority Critical patent/FR2948381B1/fr
Application filed by ONCOBIOTEK filed Critical ONCOBIOTEK
Priority to NZ597728A priority patent/NZ597728A/xx
Priority to CA2767929A priority patent/CA2767929A1/fr
Priority to CN2010800324369A priority patent/CN102471761A/zh
Priority to PCT/EP2010/059478 priority patent/WO2011009706A1/fr
Priority to MX2012001004A priority patent/MX2012001004A/es
Priority to ES10726999.5T priority patent/ES2650664T3/es
Priority to JP2012520985A priority patent/JP5758891B2/ja
Priority to AU2010275678A priority patent/AU2010275678B2/en
Priority to US13/386,522 priority patent/US9243228B2/en
Priority to EP10726999.5A priority patent/EP2456854B1/fr
Publication of FR2948381A1 publication Critical patent/FR2948381A1/fr
Priority to IL217352A priority patent/IL217352A/en
Application granted granted Critical
Publication of FR2948381B1 publication Critical patent/FR2948381B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0656—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FR0955216A 2009-07-24 2009-07-24 Procede d'obtention de myofibroblastes. Active FR2948381B1 (fr)

Priority Applications (12)

Application Number Priority Date Filing Date Title
FR0955216A FR2948381B1 (fr) 2009-07-24 2009-07-24 Procede d'obtention de myofibroblastes.
AU2010275678A AU2010275678B2 (en) 2009-07-24 2010-07-02 Method for obtaining myofibroblasts
CN2010800324369A CN102471761A (zh) 2009-07-24 2010-07-02 获得肌成纤维细胞的方法
PCT/EP2010/059478 WO2011009706A1 (fr) 2009-07-24 2010-07-02 Procede d'obtention de myofibroblastes
MX2012001004A MX2012001004A (es) 2009-07-24 2010-07-02 Proceso para la obtencion de miofibroblastos.
ES10726999.5T ES2650664T3 (es) 2009-07-24 2010-07-02 Procedimiento de obtención de miofibroblastos
NZ597728A NZ597728A (en) 2009-07-24 2010-07-02 Method for obtaining myofibroblasts
CA2767929A CA2767929A1 (fr) 2009-07-24 2010-07-02 Procede d'obtention de myofibroblastes
US13/386,522 US9243228B2 (en) 2009-07-24 2010-07-02 Process for obtaining myofibroblasts
EP10726999.5A EP2456854B1 (fr) 2009-07-24 2010-07-02 Procede d'obtention de myofibroblastes
JP2012520985A JP5758891B2 (ja) 2009-07-24 2010-07-02 筋線維芽細胞を取得する方法
IL217352A IL217352A (en) 2009-07-24 2012-01-03 A method for obtaining myofibroblasts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0955216A FR2948381B1 (fr) 2009-07-24 2009-07-24 Procede d'obtention de myofibroblastes.

Publications (2)

Publication Number Publication Date
FR2948381A1 FR2948381A1 (fr) 2011-01-28
FR2948381B1 true FR2948381B1 (fr) 2013-07-12

Family

ID=41460947

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0955216A Active FR2948381B1 (fr) 2009-07-24 2009-07-24 Procede d'obtention de myofibroblastes.

Country Status (12)

Country Link
US (1) US9243228B2 (enExample)
EP (1) EP2456854B1 (enExample)
JP (1) JP5758891B2 (enExample)
CN (1) CN102471761A (enExample)
AU (1) AU2010275678B2 (enExample)
CA (1) CA2767929A1 (enExample)
ES (1) ES2650664T3 (enExample)
FR (1) FR2948381B1 (enExample)
IL (1) IL217352A (enExample)
MX (1) MX2012001004A (enExample)
NZ (1) NZ597728A (enExample)
WO (1) WO2011009706A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104096265B (zh) * 2014-07-01 2016-03-23 温州医科大学 一种用于构建人工血管模型的三维收缩模型的制备方法
CN104630134A (zh) * 2015-02-15 2015-05-20 叶中华 阴道上皮细胞培养基及阴道上皮细胞培养方法
CN111500527A (zh) * 2020-06-30 2020-08-07 北京昱龙盛世生物科技有限公司 一种表皮干细胞的分离培养方法
US12419993B2 (en) 2021-09-07 2025-09-23 Wisconsin Alumni Research Foundation Cardiac fibroblast derived extracellular matrix
CN115197892A (zh) * 2022-06-13 2022-10-18 浙江省人民医院 一种人甲状腺乳头状癌组织中成纤维细胞的分离培养方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5573937A (en) * 1989-12-07 1996-11-12 Snow Brand Milk Products Co., Ltd. Serum free culture medium
EP1715033A4 (en) * 2004-02-13 2008-06-11 Asahi Techno Glass Corp MEDIUM FOR PREPARATION OF FEEDER CELLS FOR EMBRYONIC STEM CELLS AND FEEDER CELLS
JP5523674B2 (ja) * 2005-02-11 2014-06-18 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 植物タンパク質加水分解産物を含有する血清フリーの細胞培養液におけるポリペプチドの生産

Also Published As

Publication number Publication date
CN102471761A (zh) 2012-05-23
IL217352A0 (en) 2012-02-29
MX2012001004A (es) 2012-05-29
ES2650664T3 (es) 2018-01-19
EP2456854A1 (fr) 2012-05-30
IL217352A (en) 2016-03-31
WO2011009706A1 (fr) 2011-01-27
JP5758891B2 (ja) 2015-08-05
US20120190109A1 (en) 2012-07-26
NZ597728A (en) 2013-11-29
US9243228B2 (en) 2016-01-26
JP2013500003A (ja) 2013-01-07
EP2456854B1 (fr) 2017-08-30
FR2948381A1 (fr) 2011-01-28
CA2767929A1 (fr) 2011-01-27
AU2010275678A1 (en) 2012-02-09
AU2010275678B2 (en) 2016-06-16

Similar Documents

Publication Publication Date Title
PL2274419T3 (pl) Sposoby wytwarzania mikromieszków włosowych i brodawek de novo i stosowanie ich w badaniach in vitro i przeszczepach in vivo
WO2006050330A3 (en) Platelets from stem cells
CA3064220C (en) Liver organoid, uses thereof and culture method for obtaining them
ATE491022T1 (de) Konditionell immortalisierte adulte langzeit- stammzellen und verfahren zur herstellung und verwendung von solchen zellen
WO2016162747A3 (en) Methods and compositions for producing stem cell derived dopaminergic cells for use in treatment of neurodegenerative diseases
GB2441718A (en) Differentiation of primate pluripotent stem cells to cardiomyocyte-lineage cells
EA201071167A1 (ru) Стабилизированные олеосомные композиции и способы их получения
NZ569543A (en) Means and methods for influencing the stability of antibody producing cells
WO2011134919A3 (en) Cho cells cultivation process 0
WO2009023525A3 (en) Methods of modulating mesenchymal stem cell differentiation
CY1107014T1 (el) Χρηση θρεπτικου μεσου κυτταροκαλλιεργειας ελευθερου ορου για την παραγωγη il-18bp σε κυτταρα θηλαστικων
WO2011043629A3 (ko) 인간 지방 줄기세포의 고활성을 유도하는 방법 및 배지
FR2896511B1 (fr) Procede de culture de cellules issues du tissu adipeux et leurs applications.
TW200736399A (en) Expansion and differentiation of neural stem cells under low oxygen conditions
FR2948381B1 (fr) Procede d'obtention de myofibroblastes.
GB2453074A (en) Differentiation of primate pluripotent cells to hepatocyte-lineage cells
DE602006016735D1 (de) Verfahren zur proliferation von stammzellen
WO2013184193A3 (en) Cancer stem cells and methods of using the same
RU2016105998A (ru) Конверсия на основе малых молекул соматических клеток в клетки нейрального гребня
PT2573167T (pt) Processo para a produção de emplastros ou curativos de pele autóloga através de cultivo de queratinócitos e fibroblastos autólogos com soro autólogo para a geração de pele
EA201170025A1 (ru) Способы повышения жизнеспособности и продукции культуры клеток
WO2013041692A3 (en) Method to predict the presence of inflammation or itaconic acid, irg1 and/or protein irg1 in a subject and pharmaceutical composition for treating or preventing inflammation
GB2464075A (en) Parthenote-derived stem cells and methods of making and using them
JP2013500003A5 (enExample)
BRPI0811230A2 (pt) Métodos para cultivar uma coleção de células, para estimular a produção de células hematopoiéticas diferenciadas em uma cultura, e para tratamento de citopenia e/ou insulficiência medular óssea em um indivíduo, e, uso de uma mólecula de ligação específica para uma molécula co-estimulalatória.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9